SciELO - Scientific Electronic Library Online

 
vol.39 issue1 author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Portuguese Kidney Journal (PKJ)

On-line version ISSN 2976-0526

Abstract

CASTRO, Pedro; OLIVEIRA, Nuno  and  ALVES, Rui. C3 Glomerulonephritis: From Diagnosis to Management in a Unique Patient Case. PKJ [online]. 2025, vol.39, n.1, pp.44-48.  Epub June 01, 2025. ISSN 2976-0526.  https://doi.org/10.71749/pkj.52.

C3 glomerulopathies (C3G) are ultra‑rare diseases driven by dysregulation of the alternative pathway in the complement system, leading to glomerular C3 deposition and inflammation. C3G includes dense deposit disease (DDD) and C3 glomerulonephritis (C3GN), both associated with progression to end‑stage renal disease (ESRD). This report presents a C3GN case, highlighting diagnostic and therapeutic complexities.

A 19‑year‑old male with recurrent macroscopic hematuria triggered by respiratory infections was initially managed for suspected IgA nephropathy. Follow‑up revealed persistent low serum C3 levels, prompting a kidney biopsy that confirmed C3GN with a membranoproliferative pattern and dominant C3 deposits. Genetic testing revealed a C3 mutation and positive anti‑Factor H antibodies. Despite treatment with renin‑angiotensin‑aldosterone system blockade, steroids, and mycophenolate mofetil (MMF), the patient’s proteinuria fluctuated, requiring adjustments in immunosuppressive therapy. C3GN can mimic other glomerulonephritides such as IgA nephropathy and atypical hemolytic uremic syndrome (aHUS). Accurate diagnosis relies on kidney biopsy findings and complement studies; genetic testing can provide critical insights. While available therapies, including immunosuppressants and complement inhibitors, offer partial benefit, C3GN often progresses, underscoring the need for novel, more effective treatments.

This case illustrates the diagnostic challenges of C3GN in patients with hypocomplementemia and recurrent hematuria. It emphasizes the importance of targeted research into complement therapies to potentially improve outcomes for C3G.

Keywords : Complement C3; Glomerulonephritis; Glomerulonephritis, Membranoproliferative.

        · text in English     · English ( pdf )